Similarly, 5-year OS (SD) of childhood AML patients with mutant FLT3/ITD were inferior to patients with wild-type (50.1% (10.7%) vs 63.3% (4.8%), P < 0.001; Fig. 1B). Here, FLT3 is linked to acute myeloid leukemia.